Aspida Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 38.08%
- Profit Growth 42.62%
- Ebitda 44.48%
- Net Worth -20.38%
- Total Assets 19.36%
About Aspida Pharma
Aspida Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 November 2018 (Six years and three months 1 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Lalatendu Pradhan, Jayashree Pattanaik, and Lakshmipathy Sathish serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290KA2018PTC118376
-
Company No.
118376
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Nov 2018
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Aspida Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lalatendu Pradhan
|
Director | 09-Nov-2018 | Current |
|
Jayashree Pattanaik
|
Director | 09-Nov-2018 | Current |
|
Lakshmipathy Sathish
|
Director | 09-Nov-2018 | Current |
Financial Performance of Aspida Pharma.
Aspida Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 38.08% increase. The company also saw a substantial improvement in profitability, with a 42.62% increase in profit. The company's net worth observed a substantial decline by a decrease of 20.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aspida Pharma?
Unlock access to Aspida Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aspida Pharma?
Unlock and access historical data on people associated with Aspida Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aspida Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aspida Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
